Peng Zhong

1.8k total citations
49 papers, 1.5k citations indexed

About

Peng Zhong is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Peng Zhong has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 12 papers in Immunology. Recurrent topics in Peng Zhong's work include Immune Response and Inflammation (7 papers), Cardiovascular Function and Risk Factors (6 papers) and Heat shock proteins research (6 papers). Peng Zhong is often cited by papers focused on Immune Response and Inflammation (7 papers), Cardiovascular Function and Risk Factors (6 papers) and Heat shock proteins research (6 papers). Peng Zhong collaborates with scholars based in China, Canada and United States. Peng Zhong's co-authors include He Huang, Guang Liang, Qilu Fang, Xiaokun Li, Lintao Wang, Yuanyuan Qian, Yali Zhang, Zheng Xu, Guang Liang and Jingying Wang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Peng Zhong

47 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Zhong China 23 697 271 269 211 167 49 1.5k
Jian Feng China 22 706 1.0× 181 0.7× 306 1.1× 172 0.8× 142 0.9× 61 1.6k
Zheng Xu China 18 488 0.7× 178 0.7× 217 0.8× 141 0.7× 102 0.6× 35 1.1k
Zhangyin Ming China 19 556 0.8× 153 0.6× 236 0.9× 102 0.5× 72 0.4× 39 1.3k
Flori R. Sari Japan 19 569 0.8× 291 1.1× 117 0.4× 139 0.7× 176 1.1× 32 1.4k
Ajoe John Kattoor United States 9 581 0.8× 234 0.9× 427 1.6× 166 0.8× 136 0.8× 25 1.7k
Yue Jin China 25 881 1.3× 81 0.3× 231 0.9× 229 1.1× 150 0.9× 44 1.8k
Toru Nishinaka Japan 22 769 1.1× 89 0.3× 176 0.7× 106 0.5× 282 1.7× 62 1.5k
Mi‐Hua Liu China 20 403 0.6× 140 0.5× 106 0.4× 188 0.9× 140 0.8× 31 1.0k
Liuting Zeng China 25 714 1.0× 55 0.2× 225 0.8× 128 0.6× 173 1.0× 73 1.8k

Countries citing papers authored by Peng Zhong

Since Specialization
Citations

This map shows the geographic impact of Peng Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Zhong more than expected).

Fields of papers citing papers by Peng Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Zhong. The network helps show where Peng Zhong may publish in the future.

Co-authorship network of co-authors of Peng Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Zhong. A scholar is included among the top collaborators of Peng Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Zhong. Peng Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Peng, et al.. (2025). Deep learning predicts HER2 status in invasive breast cancer from multimodal ultrasound and MRI. Biomolecules and Biomedicine. 25(10). 2243–2251.
2.
Ding, Hua‐Sheng, et al.. (2025). Maresin 1 attenuates myocardium ischemia/reperfusion injury via SIRT1/HMGB-1/NLRP-3-related mechanisms. European Journal of Pharmacology. 998. 177456–177456. 1 indexed citations
3.
Yuan, Mingjie, et al.. (2025). Ghrelin/GHSR-1a promotes angiogenesis after myocardial infarction through the glycolytic process. Peptides. 192. 171434–171434.
4.
Yang, Haotian, Yongping Chen, Zhiqiang Wang, et al.. (2024). Dexmedetomidine affects the NOX4/Nrf2 pathway to improve renal antioxidant capacity. Journal of Pharmacy and Pharmacology. 76(7). 851–860. 3 indexed citations
5.
Zhong, Peng, Shuang Yang, Can Fang, et al.. (2024). AAV9‐mediated CIRP gene transfer protects against cardiac dysfunction and remodelling in a rat model of myocardial infarction. Journal of Cellular and Molecular Medicine. 28(19). e70084–e70084. 2 indexed citations
6.
Lan, Shijie, Sisi Shen, Jiahui Wang, et al.. (2024). Evaluation and Analysis of Traditional Chinese Medicine Treatment of Bovine Viral Diarrhea/Mucosal Disease Based on Network Pharmacology and in vitro Studies. Pharmacognosy Magazine. 21(3). 765–780. 1 indexed citations
7.
Zhong, Peng, et al.. (2023). Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report. SHILAP Revista de lepidopterología. 11(3). e7039–e7039. 7 indexed citations
8.
Li, Wei, et al.. (2022). Noise exposure and its relationship with postinfarction cardiac remodeling: implications for NLRP3 inflammasome activation. Bioengineered. 13(5). 12127–12140. 6 indexed citations
9.
Liu, Jing, Caijie Shen, Minxiao Chen, et al.. (2022). Downregulation of CIRP Prone Cells to Oxidative Injury via Regulating Nrf2 Signaling Pathway. BioMed Research International. 2022(1). 2416787–2416787. 3 indexed citations
10.
Zhong, Peng, et al.. (2022). Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment. Frontiers in Cardiovascular Medicine. 9. 997660–997660. 10 indexed citations
11.
Zhong, Peng, et al.. (2021). Ciliary neurotrophic factor overexpression protects the heart against pathological remodelling in angiotensin II-infused mice. Biochemical and Biophysical Research Communications. 547. 15–22. 9 indexed citations
12.
Zhong, Peng, et al.. (2021). AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models. Cardiovascular Toxicology. 22(1). 88–96. 7 indexed citations
13.
Fang, Qilu, Lintao Wang, Xiong Chen, et al.. (2017). Blockade of myeloid differentiation protein 2 prevents obesity‐induced inflammation and nephropathy. Journal of Cellular and Molecular Medicine. 21(12). 3776–3786. 13 indexed citations
14.
Zhong, Peng, et al.. (2017). Role of CaMKII in free fatty acid/hyperlipidemia-induced cardiac remodeling both in vitro and in vivo. Journal of Molecular and Cellular Cardiology. 109. 1–16. 39 indexed citations
15.
Yuan, Xiaoling, et al.. (2017). Salvianolic acid A protects against myocardial ischemia/reperfusion injury by reducing platelet activation and inflammation. Experimental and Therapeutic Medicine. 14(2). 961–966. 45 indexed citations
16.
Zhong, Peng & He Huang. (2017). Recent progress in the research of cold-inducible RNA-binding protein. Future Science OA. 3(4). FSO246–FSO246. 95 indexed citations
17.
Liu, Bin, Bo Pang, Yoshiki Arakawa, et al.. (2015). High mobility group A1 expression shows negative correlation with recurrence time in patients with glioblastoma multiforme. Pathology - Research and Practice. 211(8). 596–600. 11 indexed citations
18.
Zhong, Peng, Lianpin Wu, Qilu Fang, et al.. (2015). Blockage of ROS and NF-κB-mediated inflammation by a new chalcone L6H9 protects cardiomyocytes from hyperglycemia-induced injuries. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(7). 1230–1241. 58 indexed citations
19.
Zeng, Chunlai, Peng Zhong, Yunjie Zhao, et al.. (2014). Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo. Journal of Molecular and Cellular Cardiology. 79. 1–12. 145 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jian Feng Breakdown of academic impact, for papers by Zheng Xu Breakdown of academic impact, for papers by Zhangyin Ming Breakdown of academic impact, for papers by Flori R. Sari Breakdown of academic impact, for papers by Ajoe John Kattoor Breakdown of academic impact, for papers by Yue Jin Breakdown of academic impact, for papers by Toru Nishinaka Breakdown of academic impact, for papers by Mi‐Hua Liu Breakdown of academic impact, for papers by Liuting Zeng
Rankless by CCL
2026